Response to Letter to the Editor Regarding: ‘Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'
- DOI
- 10.1007/s12325-025-03436-9
- Published
- 2025-11-28
- Container
- Advances in Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-025-03436-9,
title = {Response to Letter to the Editor Regarding: ‘Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'},
author = {Mehmet A. Bilen and Benjamin Lowentritt and Ibrahim Khilfeh and Carmine Rossi and Shawn Du and Frederic Kinkead and Lilian Diaz and Dominic Pilon and Lorie Ellis and Neal D. Shore},
year = {2025},
journal = {Advances in Therapy},
doi = {10.1007/s12325-025-03436-9},
url = {https://doi.org/10.1007/s12325-025-03436-9}
}RIS
TY - JOUR TI - Response to Letter to the Editor Regarding: ‘Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer' AU - Mehmet A. Bilen AU - Benjamin Lowentritt AU - Ibrahim Khilfeh AU - Carmine Rossi AU - Shawn Du AU - Frederic Kinkead AU - Lilian Diaz AU - Dominic Pilon AU - Lorie Ellis AU - Neal D. Shore PY - 2025 JO - Advances in Therapy DO - 10.1007/s12325-025-03436-9 UR - https://doi.org/10.1007/s12325-025-03436-9 ER -
APA
Bilen, M. A., Lowentritt, B., Khilfeh, I., Rossi, C., Du, S., Kinkead, F., Diaz, L., Pilon, D., Ellis, L., & Shore, N. D. (2025). Response to Letter to the Editor Regarding: ‘Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'. Advances in Therapy. https://doi.org/10.1007/s12325-025-03436-9
Source records
- crossref · retrieved 2026-09-26T12:00:14.868Z